Pharma Journalist -

Mylan set to introduce two new HIV treatments namely, Symfi Lo and Cimduo that was sanctioned in February by the U.S Food and Drug Administration. Introducing Symfi Lo in the coming…
Read More...

Jazz Pharmaceuticals affirmed that the U.S Food and Drug Administration has conceded for filing with standard review the company's New Drug Application requesting marketing approval for…
Read More...

Cook Medical affirmed the leaders of its two new business divisions. Mark Breedlove has been named vice president of Cook’s Vascular division and DJ Sirota has been named vice president…
Read More...

Sonex Health has claimed a co-marketing agreement with Samsung NeuroLogica Corporation, the healthcare subsidiary of Samsung Electronics Co., Ltd. This relationship will position Sonex…
Read More...

Concert Pharmaceuticals asserted the next development candidate CTP-692, a novel drug for adjunctive treatment of schizophrenia, a devastating, chronic illness with significant unmet…
Read More...

U.S Food and Drug Administration ensures that patients and providers have timely and continued access to safe, effective, and high-quality medical products. FDA’s Center for Drug…
Read More...

Blink Health asserted the appointment of Former Kayak Chief Architect and General Manager of Mobile Bill O’Donnell to lead its engineering team. O’Donnell will serve as Executive Vice…
Read More...

Apnea Sciences Corporation asserted the availability of SnoreRx at selected CVS pharmacies. FDA has sanctioned SnoreRx to be denoted as the first and only oral appliance for treatment…
Read More...

The Kinetix Group Care Delivery Services has launched a Real World Evidence model,focusing on diabetes and cardiovascular conditions. As a part of this initiative, we have partnered…
Read More...

MAIA Pharmaceuticals, NJ based specialty pharmaceutical company asserted tentative approval of Sincalide for Injection NDA by the U.S. Food and Drug Administration. As far as 2013 is…
Read More...